Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lone Baandrup

Showing results (1-10 of 91) with videos related to

Pageof 10
Sort By:
Basic & Clinical Pharmacology & Toxicology|January 8, 2020
Polypharmacy in schizophreniaLone Baandrup
Ugeskrift for Laeger|September 7, 2004
[The new internship education]Lone Baandrup
Acta Psychiatrica Scandinavica|February 3, 2022
Managing the hazards of cannabis useLone Baandrup
The American Journal of Psychiatry|October 5, 2011
How dosing might influence the conclusion in an antipsychotic polypharmacy effectiveness trialLone Baandrup
Ugeskrift for Laeger|April 21, 2010
[Patients at a psychiatric residential institution in Djursland]Lone Baandrup
Bjpsych Open|November 11, 2024
Investigating the association of mechanical restraint with somatic harmful outcomes: national register-based studyLone Baandrup, Marie Kruse
Social Psychiatry and Psychiatric Epidemiology|September 28, 2015
Incident users of antipsychotics: who are they and how do they fare?Lone Baandrup, Marie Kruse
Ugeskrift for Laeger|August 20, 2005
[Organoid nevus (nevus sebaceus) dominated by the apocrine glands]Lone Baandrup, Merete Haedersdal
The Lancet. Psychiatry|January 24, 2021
Pragmatic antipsychotics trial-caution in interpretationLone Baandrup, Bjørn H Ebdrup
Neuropsychiatric Disease and Treatment|September 11, 2015
A validation of wrist actigraphy against polysomnography in patients with schizophrenia or bipolar disorderLone Baandrup, Poul Jørgen Jennum
Pageof 10

Showing results (1-10 of 91) with videos related to

Sort By:
Pageof 10
Basic & Clinical Pharmacology & Toxicology|January 8, 2020
Polypharmacy in schizophreniaLone Baandrup
Ugeskrift for Laeger|September 7, 2004
[The new internship education]Lone Baandrup
Acta Psychiatrica Scandinavica|February 3, 2022
Managing the hazards of cannabis useLone Baandrup
The American Journal of Psychiatry|October 5, 2011
How dosing might influence the conclusion in an antipsychotic polypharmacy effectiveness trialLone Baandrup
Ugeskrift for Laeger|April 21, 2010
[Patients at a psychiatric residential institution in Djursland]Lone Baandrup
Bjpsych Open|November 11, 2024
Investigating the association of mechanical restraint with somatic harmful outcomes: national register-based studyLone Baandrup, Marie Kruse
Social Psychiatry and Psychiatric Epidemiology|September 28, 2015
Incident users of antipsychotics: who are they and how do they fare?Lone Baandrup, Marie Kruse
Ugeskrift for Laeger|August 20, 2005
[Organoid nevus (nevus sebaceus) dominated by the apocrine glands]Lone Baandrup, Merete Haedersdal
The Lancet. Psychiatry|January 24, 2021
Pragmatic antipsychotics trial-caution in interpretationLone Baandrup, Bjørn H Ebdrup
Neuropsychiatric Disease and Treatment|September 11, 2015
A validation of wrist actigraphy against polysomnography in patients with schizophrenia or bipolar disorderLone Baandrup, Poul Jørgen Jennum
Pageof 10